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Abstract
Objective
Trace elements such as zinc and copper have physiological effects on neuronal 
excitability that may play a role in the etiology of intractable epilepsy. This topic 
has been rarely discussed in Iranian epileptic patients.
This study with the analysis of serum zinc and copper levels of children and 
adolescents with intractable and controlled epilepsy may identifies the potential 
role of these two trace elements in the development of epilepsy and intractability 
to antiepileptic drug treatment. 
Materials & Methods
Seventy patients between the ages of 6 months to 15 years that referred to 
Children’s Medical Center with the diagnosis of epilepsy, either controlled or 
intractable to treatment enrolled in the study. After informed parental consent 
the levels of serum zinc and copper were measured with atomic absorption 
spectrophotometer and analyzed with SPSS version 11. 
Results
35 patients were enrolled in each group of intractable (IE) and controlled epilepsy 
(CE). 71.45% of the IE and 25.72% of the CE group had zinc deficiency that was 
statistically significant. 48.58% of the IE and 45.72 of the CE group were copper 
deficient, which was not statistically significant. 
Conclusion
Our findings showed significant low serum zinc levels of patients with intractable 
epilepsy in comparison with controlled epilepsy group. 
We recommend that serum zinc level may play a role in the etiology of epilepsy 
and intractable epilepsy therefore its measurement and prescription may be 
regarded in the treatment of intractable epilepsy.
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Introduction
Seizure disorder is one of the most common neurological diseases in children and 
occurs at least one time in 4-10% of children in the first 16 years of life (1). 
Occurrence of seizure in children is not only a terrible experience for the parents 
but also have many neurologic, cognitive, psychological, and social complications 
for the child and adolescent.. Recurrent unprovoked seizures called epilepsy and its 
diagnosis are done when two or more unprovoked seizures have occurred at intervals 
longer than 24 hours intervals (1). The annual prevalence of epilepsy is 0.5-1% and 
its lifetime cumulative incidence is 3% (1). Epilepsy begins in childhood in more than 
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At least one seizure in a 6-month period despite being 
treated with at least two antiepileptic drugs was used for 
the inclusion of our patients. This definition seems more 
practical than Berg and Shinnar definition. At least one 
year consumption of AEDs was necessary criteria for 
inclusion of the patients. 
The sample size was designed according to previous 
studies and epidemiologist consults, that were 35 
patients in each group. Necessary data completed in 
designed questioners such as sex, gender, perinatal 
history, family history of epilepsy or febrile seizure 
and consumption of supplements (iron and zinc). After 
informed consent of parents, 35 patients with inclusion 
criteria of the study recruited in each group. Six 6 ml 
blood samples were collected from subjects with 1 ml 
of EDTA and its serum separated. Serum samples were 
stored frozen at -70°C until measurement of serum zinc 
and copper levels. The samples sent to the Research 
Center of Immunology, Asthma and Allergy. Cell Blood 
Counts (CBC) analysis were performed by SYSMEX 
k21 cell counter (medical electronics, TOA, Kobe, 
Japan) and zinc and copper measurements were done by 
atomic absorption spectrophotometer (GBC, SENSAA, 
Australia). The Normal range of zinc was considered 
as 60-90 µg/dl between the ages of 1-12 months, 80-
110 µg/dl between the ages of 1-10 years, 90-120 µg/dl 
between the ages of 10-15 years, and the normal range of 
copper was considered as 40-80 µg/dl in all age groups 
(8,9,10). Data were analyzed with SPSS (version 11) 
and variables were analyzed with T-test and Chi-Square. 
The P value was considered significant below 0.05.
Results
Seventy patients enrolled that consisted of 40 males and 
30 females, between the ages of 6 months to 15 years.
Overall 70% of the patients were treated with 
conventional antiepileptic drugs and 30% of them were 
treated simultaneously with both conventional and new 
AEDs. 62.9% of the patients had perinatal insults and 
in 37.1% of theme perinatal period was unremarkable. 
Family histories of epilepsy were seen in 31.4% of cases 
and family history of febrile seizures were seen in 27.1% 
of the patients. Seizure and epilepsy type classification 
of patients were as generalized tonic-clonic (70%), 
complex partial seizure (22.9%), infantile spasm (5.7%) 
half of the cases. Approximately 50 million people in the 
world have epilepsy, up to one -third of whom continue 
to have seizures despite appropriate drug treatment (2). 
Despite the importance of identifying refractory epilepsy, 
due to its comorbidities and sometimes mortalities 
different definitions presented in the literature. Drug 
resistant epilepsy may be defined as failure of adequate 
trials of two tolerated and appropriately chosen and 
used antiepileptic drugs (AEDs) schedules (whether as 
monotherapies or in combination) to achieve sustained 
seizure freedom. (3). In addition to number of AEDs 
consumption, the frequency of seizures and duration of 
follow-up are important. Berg and Shinnar recommended 
an average of more than one seizure per month for 18 
months and no more than 3 consecutive month’s seizure 
free during the follow-up period (4, 5). In our previous 
study that was conducted for the role of antioxidants 
in intractable epilepsy (2007), the patients categorized 
as intractable when they developed at least 1 seizure in 
a 6-month period despite being treated with at least 2 
antiepileptic drugs(6). 
Oxidative radicals that are produced during the 
metabolism of the brain, result in neuronal membrane 
damage, instability and epileptic discharges. 
Detoxification of the oxidative radicals is a major role 
of antioxidant enzymes such as glutathione peroxidase 
(GPx) which is a selenium-dependent enzyme and 
superoxide dismutase (SOD) that zinc and copper are its 
major constituents (7). 
Current study was carried out to identify the role of 
the trace elements in the etiology of epilepsy and its 
intractability to treatment.
Materials & Methods 
This cross-sectional study was conducted on children 
and adolescents referred to Children’s Medical Center 
during March 2011-April 2012 with the diagnosis 
of epilepsy. Epileptic patients between the ages of 6 
months to 15 years divided in two groups of intractable 
and controlled with AEDs. Symptomatic epilepsy due 
to Central Nervous System infections or metabolic and 
neurodegenerative disorders were excluded from the 
study group. 
Other exclusion criteria were clinical symptoms of zinc 
and copper deficiency and anemia. 
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 Glutaric acid decarboxylase enzyme activity is regulated 
by zinc. This enzyme plays a critical role in the synthesis 
of gamma-aminobutyric acid (GABA), which is a major 
neuron inhibitor (15). Previous studies have shown that 
levels of GABA are reduced in the Cerebrospinal fluid 
(CSF) of children with seizure disorders (15). Many 
ionic channels such as sodium and T-Type channels and 
GABA receptors which are activated by zinc and copper 
affect specific forms of epilepsy. Although specifying 
the impact of these ions as stimulants or inhibitory 
is not easily possible without great effort (15, 16). 
Experimental observations showed that zinc have both 
stimulatory and inhibitory effect on seizure activities. 
During epileptic seizure activities of humans and 
animal models, the distribution of micronutrients such 
as zinc and copper affected in the brain and peripheral 
tissues. Apparently epileptic seizure activity in mice has 
been reduced by giving copper and increased by zinc 
deprivation (15). 
In the Wojciak et al study significant lower serum zinc 
levels in patients with epilepsy were seen, in comparison 
with control healthy group. In this study serum copper 
level of epileptic patients were higher than healthy 
control group (12). In the Seven et al study patients 
with idiopathic intractable epilepsy had significantly 
decreased levels of serum zinc in comparison with 
healthy children (17). In our study patients with the 
intractable epilepsy had significantly decreased levels 
of serum zinc in comparison with the controlled group 
((P value <0.001). This finding is similar to previous 
studies of Wojciak et al and Seven et al, but the novelty 
of this study was the comparison of serum zinc between 
the intractable and controlled epilepsy group. This 
may confirm the role of zinc in the pathogenesis of 
unresponsiveness or resistance to the AEDs effects. In 
our study there was no statistically significant difference 
between serum copper levels of intractable and 
controlled epilepsy group (P value =0.811), although 
48.58% of the intractable epilepsy group and 45.72 of 
the controlled epilepsy group were copper deficient. In 
the previous study of Wojciak et al serum copper level 
of epileptic patients were higher than healthy group and 
they recommended that epilepsy may increase the copper 
level, but our study did not confirmed this hypothesis. It 
seems that more studies must be designed about the role 
and simple partial seizure (1.4%). 
Twenty-five patients (71.45%) in the intractable epilepsy 
group had zinc deficiency and 10 patients (28.55%) 
had normal zinc levels. Nine patients (25.72%) in the 
controlled epilepsy group had zinc deficiency and 26 
patients (74.28%) had normal zinc levels (Figure1). 
Patients with the intractable epilepsy had significantly 
decreased levels of serum zinc in comparison with the 
controlled group (P value <0.001). 
Eighteen patients (51.42%) in the intractable epilepsy 
group had normal serum copper level and 17 patients 
(48.58%) were copper deficient. Nineteen patients 
(54.28%) in the controlled epilepsy group had normal 
serum copper level and 16 patients (45.72) patients were 
copper deficient (Figure 2). 
There was no statistically significant difference between 
serum copper levels of intractable and Controlled 
epilepsy group (P value =0.811). 
According to the analysis, the highest numbers of cases 
in the zinc deficient group were between the ages of 
6-8-years (Figure 3) and the highest numbers of cases in 
the copper deficient group were between the ages of 6-9 
years (Figure 4).
Discussion 
About 70% of epileptic patients will be controlled with 
AEDs, but 20-25% of the patients do not have significant 
improvement in the seizure control even with the 
consumption of 2-3 AEDs (1, 11, 12). Epilepsy occur 
during childhood in more than 50% of cases, therefore 
refractory epilepsy is a major problem in this age group. 
Diagnostic confirmation of intractable epilepsy needs 
exclusion of epilepsy mimickers, incorrect drug selection 
or combination and unidentified underlying disorders 
(1).
Zinc is the second most abundant trace element in the body 
and is a cofactor for almost 300 enzymes (8,9). Copper 
is the third most abundant trace element in the body and 
is involved in electron transport and oxidation reactions 
(8,9). This shows the crucial role of zinc and copper in 
such reactions. The reasons for pharmacoresistancy of 
some types of epilepsy are not clear. Several studies 
published about the role antioxidants and some trace 
elements in the pathogenesis of seizure disorder (6,13,14, 
15,16,17).
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of copper in the pathogenesis of epilepsy.
In conclusion, we recommend that serum analysis of 
trace elements especially zinc must be considered in 
the workup of epilepsy and intractable epilepsy and 
prescription of zinc supplements may be useful in the 
prevention and treatment of epilepsy. 
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 Fig 1. Serum zinc levels in patients with intractable epilepsy and epilepsy responding to treatment
 
Fig 2. Serum copper levels in patients with intractable epilepsy and epilepsy responding to treatment.
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